Somatic DNA alterations within a single patient classified into 4 categories on the
basis of a hypothesized timing with which they were acquired during the development of
metastasis. (A) Founder alterations established in the primary tumor and
observed in all metastases (gray), shared in the primary tumor and metastases but not in
all tumors (purple), shared in 2 metastases but not the primary tumor (pink), and
private to 1 metastasis (blue). The distributions of all (B) somatic
mutations, (C) somatic CNAs, (D) DawnRank predicted mutations,
and (E) DawnRank CNAs within each patient. shared primary/mets, shared in
the primary tumor and metastases but not in all tumors; shared met-met, shared in 2
metastases but not the primary tumor.